Search by Drug Name or NDC
NDC 11822-5050-06 Mucus DM 20; 400 mg/20mL; mg/20mL Details
Mucus DM 20; 400 mg/20mL; mg/20mL
Mucus DM is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 11822-5050-06Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 11822-5050-06Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 11822-5050 |
|---|---|
| Product ID | 11822-5050_8292508a-ee9f-45da-916c-44c938be7250 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Mucus DM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dextromethorphan Hydrobromide Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 20; 400 |
| Active Ingredient Units | mg/20mL; mg/20mL |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Labeler Name | Rite Aid Corporation |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 11822-5050-06 (11822505006)
| NDC Package Code | 11822-5050-6 |
|---|---|
| Billing NDC | 11822505006 |
| Package | 177 mL in 1 BOTTLE, PLASTIC (11822-5050-6) |
| Marketing Start Date | 2019-09-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |